Market Trends of Disposable Syringes Industry
Retractable Safety Syringes Segment Expected to Witness Significant Growth Rate
- The retractable safety syringes are used for subcutaneous, intramuscular, and intravenous injections. These syringes possess a safety mechanism of automatically retracting the needle into the plunger after injection to protect an accidental needle stick and secondary use.
- A retractable safety syringe has a built-in safety mechanism to reduce the risk of needlestick injuries to healthcare workers and others. The needle on a safety syringe can be detachable or permanently attached. In some models, a sheath is placed over the needle; in others, the needle retracts into the barrel. Thus, the advantages offered by such retractable safety syringes will likely increase the segment's growth over the forecast period. Various companies provide retractable syringes, such as BD Integra retracting syringes. The syringes include significantly lower dead space volume than a traditional Luer lock syringe and needle, which may result in reduced medication waste. It also provides the clinician a choice of when to activate the safety feature, before or after the needle is withdrawn from the patient. Hence, such advantages of retractable syringes are expected to increase the demand for these syringes, which may fuel the market's growth in the near future.
- Initiatives such as growing investments and increasing product launches, given the added features of retractable safety syringes, are expected to drive the studied segment over the forecast period. For instance, in October 2021, Datwyler, a company based in Switzerland, developed the SafeR syringe, which automatically retracts the exposed needle, removing it from harm's way, preventing reapplication of the syringe, and promoting infection control. Such developments are expected to augment the market segment's growth during the forecast period.
Understand The Key Trends Shaping This Market
Download Sample
North America Expected to Hold Significant Market Share Over the Forecast Period
- North America is anticipated to hold a significant market share over the forecast period owing to the factors such as the high burden of various diseases leading to an increase in the need for diagnosis and treatment, the need for the prevention of infectious diseases, increasing approvals and launches of parenteral drugs. In addition, the initiatives undertaken by the government to prevent blood-borne infections and the establishment of new hospitals are expected to drive market growth during the forecast period.
- The high burden of hospital admissions is expected to contribute to the market's growth. For instance, the Canadian Institute for Health Information, accessed in July 2023, reported that in 2021-2022, there were almost 2.9 million acute inpatient hospitalizations in Canada compared to 2.7 million in 2020-2021. The high burden of admission in hospitals creates the need for disposable syringes for treatment and diagnosis purposes and, thus, is expected to contribute to the market's growth.
- Furthermore, the initiatives taken by the government authority to ensure proper disposal of single-use syringes and avoid multiple usages of disposable syringes are likely to augment the market growth. For instance, in April 2023, the public syringe disposal pilot program was launched in Dover by installing two-needle disposal units. This program addresses public concerns about the improper disposal of syringes in Dover, Delaware. Such initiatives create awareness about the proper use of disposable syringes, hence expected to contribute to market growth.
- Moreover, the rising new product launches are expected to increase the availability of disposable syringes in the market. For instance, in May 2021, the Department of Defense (DOD), in coordination with the Department of Health and Human Services (HHS), signed an agreement with Retractable Technologies, Inc. (RTI) to expand the production of the low dead space (LDS) safety syringes and needles. Under this agreement, the government allocated funding of USD 27.3 million. The investment would enable Retractable Technologies Inc. to install two additional automated LDS safety syringe assembly lines at its manufacturing facility in Texas, increasing the US production capacity of LDS safety syringes by approximately 75%.
- Therefore, owing to the higher risk of acquiring infectious diseases, increasing hospital admissions, growing government initiatives, and rising launches of disposable syringes, the studied market is expected to grow in the North American region over the forecast period.
Get Analysis on Important Geographic Markets
Download Sample
